Traitement du tremblement essentiel : des médicaments à la stimulation cérébrale profonde

Elble, 2006, Report from a U.S. conference on essential tremor, Mov Disord, 21, 2052, 10.1002/mds.21157 Zesiewicz, 2005, Practice parameter: therapies for essential tremor: report of the Quality Standards Sub-committee of the American Academy of Neurology, Neurology, 64, 2008, 10.1212/01.WNL.0000163769.28552.CD Lorenz, 2007, Update on pathogenesis and treatment of essential tremor, Curr Opin Neurol, 20, 447, 10.1097/WCO.0b013e3281e66942 Paris-Robidas, 2012, Defective dentate nucleus GABA receptors in essential tremor, Brain, 135, 105, 10.1093/brain/awr301 Placantonakis, 2004, Fundamental role of inferior olive connexion 36 in muscle coherence during tremor, Proc Natl Acad Sci U S A, 101, 7164, 10.1073/pnas.0400322101 Schnitzler, 2009, Synchronized brain network associated with essential tremor as revealed by magnetoencephalography, Mov Disord, 24, 1629, 10.1002/mds.22633 Popa, 2013, Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial, Brain Stimulation, 6, 175, 10.1016/j.brs.2012.04.009 Louis, 2007, Neuropathological changes in essential tremor: 33 cases compared with 21 controls, Brain, 130, 3297, 10.1093/brain/awm266 Rajput, 2012, Essential tremor is not dependent upon cerebellar Purkinje cell loss, Parkinsonism Relat Disord, 18, 626, 10.1016/j.parkreldis.2012.01.013 Deuschl, 2011, Treatment of patients with essential tremor, The Lancet Neurol, 10, 148, 10.1016/S1474-4422(10)70322-7 Winkler, 1971, The control of essential tremor by propranolol, Trans Am Neurol Assoc, 96, 66 Jefferson, 1979, Beta-adrenoreceptor antagonists in essential tremor, J Neurol Neurosurg Psychiatry, 42, 904, 10.1136/jnnp.42.10.904 Schneider, 2014, The treatment of tremor, Neurotherapeutics, 11, 128, 10.1007/s13311-013-0230-5 Larsen, 1982, Atenolol vs. propranolol in essential tremor. A controlled, quantitative study, Acta Neurol Scand, 66, 547, 10.1111/j.1600-0404.1982.tb03141.x O'Suilleabhain, 1998, Time-frequency analysis of tremors, Brain, 121, 2127, 10.1093/brain/121.11.2127 Rosenfeld, 1997, Topiramate: a review of preclinical, pharmacokinetic and clinical data, Clin Ther, 19, 1294, 10.1016/S0149-2918(97)80006-9 Ondo, 2006, Topiramate in essential tremor: a double-blind, placebo-controlled trial, Neurology, 66, 672, 10.1212/01.wnl.0000200779.03748.0f Hedera, 2013, Pharmacotherapy of essential tremor, J Cent Nerv Syst Dis, 5, 43, 10.4137/JCNSD.S6561 Hedera, 2017, Emerging strategies in the management of essential tremor, Therap Adv Neurol Disord, 10, 137, 10.1177/1756285616679123 Llinas, 1986, Oscillatory properties of guinea-pig inferior olivary neurones and their pharmacological modulation: an in vitro study, J Physiol, 376, 163, 10.1113/jphysiol.1986.sp016147 Haubenberger, 2013, Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study, Neurology, 80, 933, 10.1212/WNL.0b013e3182840c4f Martin, 2006, Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor, Mov Disord, 21, 1641, 10.1002/mds.20940 Benabid, 1991, Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus, Lancet, 337, 403, 10.1016/0140-6736(91)91175-T Ondo, 2001, Thalamic deep brain stimulation: comparison between unilateral and bilateral placement, Arch Neurol, 58, 218, 10.1001/archneur.58.2.218 Voges, 2007, Thirty days complication rate following surgery performed for deep brain stimulation, Mov Disord, 22, 1486, 10.1002/mds.21481